Difficulty: Medium
Average Score: 87%
Practice
A 31-year-old G3P2002 woman is 30 weeks pregnant and presents for her routine checkup. She has known HIV disease, which she did not have during her two other pregnancies. Her viral load is 1,000 and CD4 count is 455. In order to decrease the likelihood of transmission of HIV disease to her baby, she has been advised to have a cesarean section, not breastfeed, and take an antiviral for HIV disease. What HIV disease medication has been proven to decrease the likelihood of the transmission of HIV disease from the mother to the fetus?
Correct answer
D
Rationale
In the given scenario, the correct answer is D) Zidovudine. Zidovudine, also known as AZT, is part of a group of medications called nucleoside reverse transcriptase inhibitors (NRTIs). It has been proven to significantly reduce the risk of mother-to-child transmission of HIV when taken during pregnancy and labor, as well as when given to the newborn for a few weeks after birth. Zidovudine works by inhibiting the replication of the HIV virus, thereby reducing the viral load in the mother and the risk of transmission to the fetus.
Now, let's discuss why the other options are incorrect:
A) Efavirenz: Efavirenz is not recommended for use during pregnancy, especially in the first trimester, as it has been associated with potential risks to the developing fetus.
B) Enfuvirtide: Enfuvirtide is not used for preventing mother-to-child transmission of HIV. It is a fusion inhibitor used in the treatment of HIV infection in adults and children.
C) Indinavir: Indinavir is a protease inhibitor used in the treatment of HIV infection but is not specifically indicated for reducing the risk of mother-to-child transmission.
Educational Context:
Understanding the appropriate medications for managing HIV in pregnant women is crucial in preventing transmission to the fetus. Zidovudine is a cornerstone in the prevention of mother-to-child transmission of HIV and is recommended as part of the standard regimen in pregnant women with HIV. Healthcare providers need to be well-informed about the safety and efficacy of different antiretroviral medications during pregnancy to provide optimal care for both the mother and the baby.
Now, let's discuss why the other options are incorrect:
A) Efavirenz: Efavirenz is not recommended for use during pregnancy, especially in the first trimester, as it has been associated with potential risks to the developing fetus.
B) Enfuvirtide: Enfuvirtide is not used for preventing mother-to-child transmission of HIV. It is a fusion inhibitor used in the treatment of HIV infection in adults and children.
C) Indinavir: Indinavir is a protease inhibitor used in the treatment of HIV infection but is not specifically indicated for reducing the risk of mother-to-child transmission.
Educational Context:
Understanding the appropriate medications for managing HIV in pregnant women is crucial in preventing transmission to the fetus. Zidovudine is a cornerstone in the prevention of mother-to-child transmission of HIV and is recommended as part of the standard regimen in pregnant women with HIV. Healthcare providers need to be well-informed about the safety and efficacy of different antiretroviral medications during pregnancy to provide optimal care for both the mother and the baby.